Navigation Links
Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009
Date:2/17/2009

S CONSOLIDATED BALANCE SHEETS December 31, June 30, 2008 2008 (Unaudited) ASSETS CURRENT ASSETS: Cash $ 76,379,860 $ 48,195,798 Restricted cash 6,580,962 7,839,785 Investments 532,724 2,055,241 Accounts receivable, net of allowance for doubtful accounts of $267,957 and $155,662, respectively 26,101,618 24,312,077 Accounts receivable - related parties 188,022 673,808 Inventories 4,978,846 3,906,174 Other receivables 2,324,562 152,469 Other receivables - related parties 237,343 -- Advances to suppliers and other assets 124,578 1,718,504 Total current assets 117,448,515 88,853,856 PLANT AND EQUIPMENT, net 11,125,526 11,225,844 OTHER ASSETS: Restricted investments 600,075 2,481,413 Financing costs, net 1,576,793 1,916,944 Intangible assets, net 9,823,785 9,916,801 Total other assets 12,000,653 14,315,158 Total other assets $ 140,574,694 $ 114,394,858 LIABILITIES AND SHAREHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable $ 2,924,891 $ 2,341,812 Short term bank loans 2,200,500 2,772,100 Notes payable 6,580,962 5,843,295
'/>"/>
SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009
2. Genesis HealthCare Promotes Wendy LaBate To Senior Vice President of Operations for the Northeast Area
3. AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences
4. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2009 Results on February 4, 2009
5. Genesis Pharmaceuticals Appoints KPMG to Help Develop a SOX 404 Compliance Program
6. OmegaGenesis Announces Angiogenesis Application Collaboration
7. Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
8. Tissue Genesis Applies CE Mark to Its Adult Stem Cell Isolation System
9. Cardiogenesis Reports Third Quarter 2008 Results
10. ThermoGenesis Presentation at Rodman & Renshaw Conference
11. Genesis Pharmaceuticals Launches New Corporate Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... YORK , Feb. 26, 2015 S&P ... Factual Stock Report coverage on MabVax Therapeutics Holdings ... (MBVX) is a clinical stage biotechnology company focused on ... unmet medical needs in the treatment of cancer. MabVax ... based on the protective immune responses generated by patients ...
(Date:2/26/2015)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") ... develops and commercializes proprietary technologies and products for advanced ... for the fiscal first quarter ended December  31, 2014. ... dollars (CAD), unless otherwise stated. "During ... from our existing customers and add to our sales ...
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
(Date:2/26/2015)... Woodbridge, NJ (PRWEB) February 26, 2015 ... and its affiliated companies, Wilentz, Goldman & ... in a trade secrets lawsuit against Genewiz Inc. in ... illegally obtained and utilized GenScript’s trade secrets, and that ... The court entered an order denying motions for ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... In response to recent press coverage concerning investment ... Minnesota, Burrill & Company would like to clarify that ... have been in active discussions for several months with ... project," said G. Steven Burrill, CEO, Burrill & Company. ...
... National Ergonomics Conference and Exposition (ErgoExpo) at Caesars Palace, ... on the importance of ergonomics, safety and employee wellness ... topics of program management and return on investment, the ... specifically for those working in offices, industrial, lab, healthcare, ...
... Sept. 16 Regado Biosciences, a privately held company ... agents, announced that David J. Mazzo, PhD, President and ... Sciences Conference.  Dr. Mazzo,s presentation will be given at ... Wednesday, September 22, 2010 at 8:00 a.m. EDT in ...
Cached Biology Technology:Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run 22010 National Ergonomics Conference Coming To Las Vegas, Nov. 30 - Dec. 3 With Larger Expo; 22010 National Ergonomics Conference Coming To Las Vegas, Nov. 30 - Dec. 3 With Larger Expo; 32010 National Ergonomics Conference Coming To Las Vegas, Nov. 30 - Dec. 3 With Larger Expo; 4Regado Biosciences to Present at the UBS Global Life Sciences Conference on September 22, 2010 in New York City 2Regado Biosciences to Present at the UBS Global Life Sciences Conference on September 22, 2010 in New York City 3
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... CEO Conference on January 29 th at 10:30 ... CEO of NXT-ID will present and host a live ... wallet and its full suite of biometric technologies. Investors ...
(Date:1/22/2015)... 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased ... State of Washington,s Department of Licensing, ... and central issuance system for driver,s licenses and identification cards ... planning and development will start in January 2015, with enrollment ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 2CEO of NXT-ID, Inc. to Discuss Company's Biometric Technologies at RedChip Online Conference January 29th 3Valid USA Signs Contract For Washington Driver's License Issuance 2
... The initial results of the first computer model ... representation of individual clouds have been analyzed by ... Research Center (IPRC) at the University of Hawai`i ... Technology (JAMSTEC), and the University of Tokyo. ...
... learn how to do something by trying it ourselves may ... in neuroscience. It turns out that humans, primates, some birds, ... in the same pattern whether performing or just observing a ... learning motor tasks involving hand eye coordination, and possibly also ...
... Tufts University,s School of Engineering has been selected ... the field of catalysis, particularly for new insights ... fuel conversion and pollutant processes. Election ... members by their peers. Flytzani-Stephanopoulos, professor in the ...
Cached Biology News:How mirror neurons allow us to learn and socialize by going through the motions in the head 2Tufts University Prof. Maria Flytzani-Stephanopoulos named as AAAS Fellow 2